Symbol: |
SLC6A13
|
Description: |
solute carrier family 6 (neurotransmitter transporter, GABA), member 13 [Source:HGNC Symbol;Acc:11046]
|
Location: |
Chr12:329789-372039[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:102
Gene |
Compound |
Gen_sig |
Exp_pattern |
SLC6A13 |
NSC 105348 |
0.026 |
Up |
SLC6A13 |
Ethanesulfonic acid, compd. with 4-[3-[p-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)benzyl]ureido]-o-toluenesulfonyl fluoride (1:1) |
0.028 |
Down |
SLC6A13 |
Methanaminium, N-[bis[4-(dimethylamino)phenyl]methylene]-2,5-cyclohexadien-1-ylidene]-N-methyl-, 1,2-benzenedicarboxylate (1:1) |
0.033 |
Down |
SLC6A13 |
NSC 292596 |
0.019 |
Up |
SLC6A13 |
CYCLOMETHYLENOMYCIN A |
0.017 |
Up |
SLC6A13 |
Hydrazinecarbodithioic acid, [1-(2-pyridinyl)ethylidene]-, phenylmethyl ester |
0.024 |
Up |
SLC6A13 |
CHALCONE ANALOG |
0.036 |
Down |
SLC6A13 |
CYTOVARICIN |
0.024 |
Down |
SLC6A13 |
NSC 41274 |
0.049 |
Up |
SLC6A13 |
C.I. 37559 |
0.015 |
Up |
SLC6A13 |
NSC 611274 |
0.042 |
Up |
SLC6A13 |
Benzo[1,2-c:4,5-c']dipyrrole-1,3,5,7(2H,6H)-tetraimine |
0.042 |
Up |
SLC6A13 |
Carbonimidodithioic acid, [5-(4-nitrophenyl)-1,3,4- thiadiazol-2-yl]-, dimethyl ester |
0.009 |
Up |
SLC6A13 |
2-Propen-1-one, 3-(l,3-benzodioxol-5-yl)-1-(1,4-dioxo- 2,6,7-trimethylquinoxalin-3-yl)- |
0.048 |
Up |
SLC6A13 |
Naphth[2,3-d]thiazole-4,9-dione, 2-[(2-methylphenyl)amino]- |
0.024 |
Down |
Expression pattern: Sensitivity / Resistance
Total:7 Current:1
[First] [Prev]  Next Last 
|
SNP:
~ Export ~
|
Records:28
Total:2 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:98
Total:7 Current:1
[First] [Prev]  Next Last 
|